| | | |
Recurrence-free survival in cN0M0 cases
|
|---|
|
Variable
|
Unfavorable/favorable characteristics
|
No. of Patients
|
Analysis
|
Relative risk
|
95% confidential interval
|
P value
|
|---|
|
p-SUVmax*
|
high/low
|
26/26
|
Univariate (U)
|
14.361
|
4.283 - 64.472
|
0.00940
|
|
Multivariate (M)
|
1.714
|
0.021 - 142.351
|
0.64270
|
|
pAkt (Ser473)
|
high/low
|
26/26
|
U
|
5.895
|
1.688 - 50.514
|
0.03910
|
|
M
|
2.374
|
0.062 - 367.647
|
0.78520
|
|
pAkt (Thr308)
|
high/low
|
25/27
|
U
|
5.321
|
1.621 - 45.612
|
0.04810
|
| |
2.157
|
0.069 - 397.026
|
0.79130
|
|
pS6
|
high/low
|
26/26
|
U
|
3.994
|
0.466 - 34.272
|
0.12190
|
|
M
| | | |
|
Grade
|
4/3/2/1
|
2/13/28/9
|
U
|
11.397
|
3.320 - 33.119
|
0.00007
|
|
M
|
31.171
|
1.836 - 529.228
|
0.01730
|
|
pT
|
4,3/2,1
|
13/39
|
U
|
7.807
|
1.920 - 31.753
|
0.00410
|
|
M
|
5.151
|
0.187 - 151.279
|
0.15370
|
|
v
|
1/0
|
24/28
|
U
|
4.941
|
1.016 - 24.035
|
0.04780
|
|
M
|
2.355
|
0.156 - 35.559
|
0.53630
|
|
cell type
|
sarcomatoid/non-cc/cc*
|
3/9/40
|
U
|
7.051
|
2.634 - 18.876
|
0.00010
|
|
M
|
1.029
|
0.091 - 11.577
|
0.78180
|
-
p-SUVmax*: SUVmax value in the primary tumor.
-
sarcomatoid/non-cc/cc*: sarcomatoid differentiation/non-clear cell RCC/clear cell RCC.
